Clinical Trial Update: Study Using Pregnenolone to Treat Bipolar Depression [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating pregnenolone for the treatment of bipolar depression has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder

Drugs mentioned

• Pregnenolone (pregnenolone)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Bipolar Disorder, Major Depressive Disorder | Phase 4 | Status: COMPLETED | Results posted: 2016-03-31